A comparison of two medical devices that assess how people sense the need to empty their bowels
| ISRCTN | ISRCTN12953305 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN12953305 |
| ClinicalTrials.gov (NCT) | Nil known |
| Clinical Trials Information System (CTIS) | Nil known |
| Integrated Research Application System (IRAS) | 331715 |
| Protocol serial number | IRAS 331715 |
| Sponsor | Newcastle upon Tyne Hospitals NHS Foundation Trust |
| Funder | Newcastle upon Tyne Hospitals NHS Foundation Trust |
- Submission date
- 24/02/2025
- Registration date
- 21/07/2025
- Last edited
- 21/07/2025
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Digestive System
Plain English summary of protocol
Background and study aims
The human body stores stool (poo) within the rectum, which is between the end of the large bowel and the anus, where stool exits the body. Some people develop issues with sensing that stool is there, or can sense it too much. This can cause symptoms that decrease quality of life, such as leaking stool, pain, and going to the toilet too much or too little. One example where this occurs is a condition called irritable bowel syndrome, which currently affects 3.2 million people in the UK.
The majority of hospitals in the UK assess sensations felt within the rectum by inflating a small elastic (stretchy) balloon, placed within the rectum, with air. The patient is asked at what time they feel different sensations, and from this information a diagnosis can be made (using the London Classification system), which can help their doctor to devise a treatment plan. A less common device, called a rectal barostat, can also be used to test sensations in the rectum. Instead of an elastic balloon, the rectal barostat inflates a plastic bag that is non-elastic, with air. Since the rectal barostat bag is non-elastic, it can also measure the capacity of the rectum, and tell us how stretchy its walls are. In this study, patients who attend for the elastic balloon test as part of standard care, would also undergo assessment with the rectal barostat in the same hospital appointment. This study aims to find out whether patients tested with the elastic balloon receive the same diagnosis as when they are tested with the rectal barostat. This research is important as it may show that using the rectal barostat changes someone’s diagnosis, and suggests more centres should be using this device instead of the elastic balloon so we can accurately diagnose more patients.
Who can participate?
Patients aged over 18 and under 90 years who meet one or more of the following indications for anorectal physiology investigations: symptoms of constipation or disorder of evacuation, faecal incontinence, functional anorectal pain, faecal urgency and frequency of moving bowels, constant urge to move bowels, has had a previous lower gastrointestinal tract investigation (colonoscopy, flexible sigmoidoscopy, defecating proctogram, digital rectal examination, CT colon) in the past 2 years.
What does the study involve?
Patients who have been referred for anorectal physiology studies as part of standard care will be considered to participate in the study. These tests routinely include endoanal ultrasound, anorectal manometry, and rectal sensitivity testing using elastic balloon distension. Participants will additionally undergo the rectal barostat test. Each participant will be offered a rectal sensitivity testing questionnaire to be completed in reception following their appointment, and once each participant has completed the exit questionnaire they will exit the study.
What are the possible benefits and risks to participating?
Participants will receive the results of the rectal barostat test within their clinic report provided to their consultant.
There is a burden of additional time required from the patient, which is about 30 minutes additional to their standard anorectal physiology appointment time. To minimise this burden, the additional barostat test will be performed at the same time as their standard care appointment, to avoid additional travel costs and time. The barostat test also carries a risk of pain, discomfort, bleeding, and perforation of the rectum (less than 1 in 1000), the same as standard rectal sensitivity testing using the elastic balloon, which the patients will also be undergoing as part of their standard anorectal physiology appointment. To minimise pain and discomfort, lubrication is used to insert the catheter and the participant is advised they can withdraw their consent at any point, and the test will be abandoned. To minimise the risk of bleeding, the test will be abandoned if there is any resistance during insertion of the catheter and participants are excluded from the study if they suffer from excessive or unexplained rectal bleeding. Any participants with risk factors of rectal perforation, such as previous pelvic surgery, pelvic radiotherapy, or inflammatory bowel disease are excluded from the study (according to exclusion criteria), and the barostat automatically deflates if the pressure of the rectal wall exceeds 80 mmHg.
Where is the study run from?
The study sponsor is Newcastle upon Tyne Hospitals NHS Foundation Trust. The study sites include the Royal Victoria Infirmary (Newcastle upon Tyne), and the University Hospital of North Durham (UK).
When is the study starting and how long is it expected to run for?
July 2023 to January 2026
Who is funding the study?
Newcastle upon Tyne Hospitals NHS Foundation Trust (UK)
Who is the main contact?
Dr Helen Parker, helen.parker38@nhs.net
Contact information
Scientific, Principal investigator
Newcastle Hospitals NHS Foundation Trust
NMPCE, Leazes Wing
Royal Victoria Infirmary
Newcastle upon Tyne
NE14LP
United Kingdom
 ORCID ID |
0000-0002-3849-5008 |
|---|---|
| Phone | +44 (0)191 282 4493 |
| helen.parker38@nhs.net |
Public
Newcastle Hospitals NHS Foundation Trust
NMPCE, Leazes Wing
Royal Victoria Infirmary
Newcastle upon Tyne
NE14LP
United Kingdom
| Phone | +44 (0)191 282 4493 |
|---|---|
| natalie.page9@nhs.net |
Study information
| Primary study design | Interventional |
|---|---|
| Study design | Feasibility randomized interventional multi-site study |
| Secondary study design | Randomised controlled trial |
| Participant information sheet | 46893_PIS_01Feb24_V1.3.pdf |
| Scientific title | A feasibility study to assess rectal sensitivity using elastic balloon distension versus a rapid rectal barostat bag: is there an agreement in London Classification diagnoses? |
| Study objectives | This feasibility study will help investigate key variables required to inform a future definitive study, which will aim to determine whether patients receive a different diagnosis of rectal sensitivity dependent upon the test used. Moreover, a definitive study will address the potential impact of rectal sensitivity testing methodologies on patient outcomes. |
| Ethics approval(s) |
Approved 14/02/2024, Dulwich Research Ethics Committee (Health Research Authority, 2nd Floor, 2 Redman Place, Stratford, London, E20 1JO, United Kingdom; +44 (0)207 104 8094; dulwich.rec@hra.nhs.uk), ref: 23/PR/1521 |
| Health condition(s) or problem(s) studied | Patients with bowel symptoms including symptoms of constipation or disorder of evacuation, faecal incontinence functional anorectal pain, faecal urgency and frequency of moving bowels, or a constant urge to move bowels |
| Intervention | Intervention: Rectal barostat test. All participants will have the rectal barostat test, but the order of tests will be changed per patient to avoid bias on the order of tests influencing the results. Patients will either receive procedure A or procedure B: Procedure A: Anorectal manometry, elastic balloon distension, endoanal ultrasound, rectal barostat Procedure B: Rectal barostat, endoanal ultrasound, anorectal manometry, elastic balloon distension The basic details (e.g. short title, study overview) of the study will be registered with the online randomisation software, Sealed Envelope (https://www.sealedenvelope.com/). The simple randomisation service for non-commercial clinical studies will be selected. At each site a secure NHS email address accessible only to the research team will be used to perform each randomisation. The unique participant randomisation number will be entered into the software. The software will then automatically randomise to procedure A or procedure B. |
| Intervention type | Other |
| Primary outcome measure(s) |
1. The number of patients who were eligible to participate in the study per site from the start to the end of recruitment |
| Key secondary outcome measure(s) |
1. The London Classification diagnosis per patient as assessed by the elastic balloon distension test and the rectal barostat test at the end of the study |
| Completion date | 01/01/2026 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Lower age limit | 18 Years |
| Upper age limit | 90 Years |
| Sex | All |
| Target sample size at registration | 30 |
| Key inclusion criteria | 1. Aged over 18 years 2. Aged under 90 years 3. Male or nonpregnant female 4. Meets 1 or more of the following indications for anorectal physiology investigations: symptoms of constipation or disorder of evacuation, faecal incontinence functional anorectal pain, faecal urgency and frequency of moving bowels, constant urge to move bowels 5. Has had a previous lower gastrointestinal tract investigation (colonoscopy, flexible sigmoidoscopy, defecating proctogram, digital rectal examination, CT colon) in the past 2 years 6. Able to understand both written and verbal English |
| Key exclusion criteria | 1. Creutzfeldt-Jakob disease 2. Pregnancy 3. Previous rectal surgery 4. Previous pelvic radiotherapy 5. Haemorrhoid banding in past 2 weeks 6. Haemorrhoidectomy in past 10 weeks 7. Reporting of change of bowel habits, rectal bleeding, or weight loss with no endoscopic investigations performed since symptoms commenced 8. History of inflammatory bowel disease 9. History of colorectal or anal cancer 10. Lack of capacity to consent 11. Over 90 years old 12. Under 18 years old |
| Date of first enrolment | 29/04/2024 |
| Date of final enrolment | 01/01/2026 |
Locations
Countries of recruitment
- United Kingdom
- England
Study participating centres
Newcastle upon Tyne
NE1 4LP
United Kingdom
North Road
Durham
DH1 5TW
United Kingdom
Results and Publications
| Individual participant data (IPD) Intention to share | No |
|---|---|
| IPD sharing plan summary | Not expected to be made available |
| IPD sharing plan | The datasets generated during the current study are not expected to be made available publicly due to containing private and confidential patient data. However, the results will be shared with each participant's individual consultant. |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Participant information sheet | version 1.3 | 01/02/2024 | 24/02/2025 | No | Yes |
| Participant information sheet | Participant information sheet | 11/11/2025 | 11/11/2025 | No | Yes |
| Protocol file | 16/02/2024 | 24/02/2025 | No | No |
Additional files
- 46893_PIS_01Feb24_V1.3.pdf
- Participant information sheet
- 46893_PROTOCOL_16Feb24.pdf
- Protocol file
Editorial Notes
24/02/2025: Study's existence confirmed by the HRA.
